Table 4.
Distribution of Electrocardiographic (ECG) Parameters Based on Antiretroviral Regimen
| Antiretroviral Regimen | ||||
|---|---|---|---|---|
| ECG Parameter | EFAVERENZ BASED (n = 94) | NEVIRAPEN BASED (n = 63) | p-value | |
| Heart rate (beats/min) | 87 (77.0–96.5) | 88 (77–97) | 86 (76–94) | 0.435 |
| PRI (ms) | 168 (144–183) | 168 (141.5–182) | 170 (148–192) | 0.696 |
| QRSD (ms) | 88 (82–98) | 86 (81.5–98.0) | 90 (82–100) | 0.19 |
| n% | n% | n% | ||
| SINUS RYTHYM | - | |||
| Yes | 157 (100.0) | 94 (59.9) | 63 (40.1) | |
| No | 0 (0.0) | 0 (0.00) | 0 (0.00) | |
| SINUS TACHYCAARDIA | 0.452 | |||
| Yes | 28 (17.8) | 16 (57.1) | 12 (42.9) | |
| No | 129 (82.2) | 78 (60.5) | 51 (39.5) | |
| SINUS BRADYCARDIA | 0.401 | |||
| Yes | 1 (0.6) | 0 (0.0) | 1 (100) | |
| No | 156 (99.4) | 94 (60.3) | 62 (39.7) | |
| NORMAL AXIS | 0.264 | |||
| Yes | 148 (94.3) | 90 (60.8) | 58 (32.9) | |
| No | 9 (5.7) | 4 (44.4) | 5 (55.6) | |
| RAD | 0.643 | |||
| Yes | 2 (1.3) | 1 (50) | 1 (50) | |
| No | 155 (98.7) | 93 (60) | 62 (40) | |
| LAD | 0.407 | |||
| Yes | 8 (5.1) | 4 (50) | 4 (50) | |
| No | 149 (94.9) | 90 (60.4) | 59 (39.6) | |
| LVH | 0.317 | |||
| Yes | 5 (3.2) | 2 (40) | 3 (60) | |
| No | 152 (96.8) | 92 (60.5) | 60 (39.5) | |
| LAE | 0.643 | |||
| Yes | 2 (1.3) | 1 (50) | 1 (50) | |
| No | 155 (98.7) | 93 (60.0) | 62 (40.0) | |
Note: P-values of categorical variables were computed using the 2×2 Fisher exact test while that of continuous variables were done using Mann–Whitney U-test.
Abbreviations: QRSD, QRS duration; PRI, PR Interval; LAD, left axis deviation; RAD, right axis deviation; LVH, left ventricular hypertrophy; LAE, left atrial enlargement.